PharmaCyte Biotech, Inc. Balance Sheet
PMCB|14 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 14 fiscal years. All figures from audited SEC 10-K filings.
PharmaCyte Biotech, Inc. had $55M in total assets and $28M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15.2M | $50.2M | $68.0M | - | - | - | - | - | - | - | - | - | $15.7K | $57.2K |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | $6.8K |
| Current Assets | $22.4M | $50.4M | $68.1M | $85.5M | $2.3M | $1.0M | $653.4K | $1.3M | $3.5M | $2.0M | $4.2M | $4.2M | $1.8M | $1.1M |
| Total Assets | $55.2M | $59.9M | $73.3M | $90.6M | $7.4M | $6.2M | $5.8M | $6.4M | $8.7M | $7.2M | $9.3M | $9.3M | $2.9M | $2.1M |
| Current Liabilities | $2.9M | $7.4M | $586.6K | $704.4K | $724.8K | $1.0M | $742.9K | $644.2K | $580.2K | $637.6K | $373.7K | $373.7K | $3.8M | $3.8M |
| Shareholders' Equity | $27.6M | $72.7M | $89.9M | $6.7M | $5.1M | $5.0M | $5.8M | $8.1M | $6.5M | $7.8M | -$2.3M | -$2.3M | -$2.3M | -$2.7M |